Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older

التفاصيل البيبلوغرافية
العنوان:	Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older
المؤلفون:	Altawalbeh, Shoroq M., Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K., Smith, Kenneth J.
المصدر:	In Vaccine 30 April 2024 42(12):3024-3032
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	0264410X
DOI:	10.1016/j.vaccine.2024.04.002